With 6.07 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.78 million shares. The 52-week range on XERS shows that it touched its highest point at $4.50 and its lowest point at $1.69 during that stretch. It currently has a 1-year price target of $6.08. Beta for the stock currently stands at 1.30.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of XERS was up-trending over the past week, with a rise of 24.39%, but this was up by 26.80% over a month. Three-month performance surged to 28.57% while six-month performance rose 81.42%. The stock gained 85.08% in the past year, while it has gained 35.40% so far this year. A look at the trailing 12-month EPS for XERS yields -0.38 with Next year EPS estimates of 0.10. For the next quarter, that number is -0.05. This implies an EPS growth rate of 77.32% for this year and 215.11% for next year.
Float and Shares Shorts:
At present, 149.43 million XERS shares are outstanding with a float of 142.31 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for XERS since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.33285 being high and -$0.39417 being low. For XERS, this leads to a yearly average estimate of -$0.35913. Based on analyst estimates, the high estimate for the next quarter is -$0.01 and the low estimate is -$0.03. The average estimate for the next quarter is thus -$0.02.